Ppe Net - Protagonist Therapeutics Inc (NASDAQ:PTGX) - Alpha Spread

Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 45.92 USD 2.57% Market Closed
Market Cap: 2.7B USD
Have any thoughts about
Protagonist Therapeutics Inc?
Write Note

Protagonist Therapeutics Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Protagonist Therapeutics Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Protagonist Therapeutics Inc
NASDAQ:PTGX
PP&E Net
$12m
CAGR 3-Years
25%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.1B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.8B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.3B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
20%

See Also

What is Protagonist Therapeutics Inc's PP&E Net?
PP&E Net
12m USD

Based on the financial report for Jun 30, 2024, Protagonist Therapeutics Inc's PP&E Net amounts to 12m USD.

What is Protagonist Therapeutics Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
8%

Over the last year, the PP&E Net growth was 265%. The average annual PP&E Net growth rates for Protagonist Therapeutics Inc have been 25% over the past three years , 8% over the past five years .

Back to Top